India's intimate care market expands beyond sanitary pads with bold innovations
India's intimate care market expands beyond sanitary pads with bold innovations
India's intimate care market expands beyond sanitary pads with bold innovations
The intimate care market in India is evolving rapidly. What was once dominated by sanitary pads now includes a wide range of products, from period underwear to postpartum recovery items. Startups in this space continue to innovate and expand their offerings. Last year, Sirona’s founders reacquired the feminine hygiene brand from Good Glamm Group. This move highlighted the growing independence of startups in the sector. Earlier this year, HealthFab secured ₹20 Cr in funding from Atomic Capital, signalling strong investor interest.
The market has also seen strategic partnerships. Intimate care startup Ugees joined forces with premium innerwear brand Krvvy to broaden its reach. Digital-first brands have played a key role in this growth, focusing on localisation and educating consumers about new products.
Access has improved thanks to ecommerce marketplaces and quick commerce platforms. These channels have made intimate care products more available across the country. However, the market remains fragmented, making it difficult to measure its total size accurately. Success in this category hinges on product quality, brand trust, and strong distribution networks. Habit formation among consumers is another critical factor. As awareness grows, the sector is expanding beyond hygiene into wellness, recovery, and lifestyle products.
German nursing care reform faces delay as DAK-Gesundheit demands major revisions
A last-minute plea to halt the reform exposes deep flaws in Germany's care system. Will the government rewrite the rules—or risk financial chaos for families and towns?
Region's healthcare transformation brings new hospitals and cutting-edge upgrades
From rural clinics to urban polyclinics, this region's healthcare overhaul is setting new standards. Discover how 149 new facilities and global-trained doctors are reshaping patient care.
FDA's peptide safety review sparks conflict-of-interest concerns this July
From muscle growth to anti-aging, peptides promise miracles—but can the FDA's review be trusted with insiders profiting from the same drugs? A deep dive into the controversy.
Debt repayments now outpace healthcare spending in poorer nations
Kenya spends 29% of revenue on debt—three times its healthcare budget. The IMF's austerity push deepens inequality and strains public services.